Vertex Pharmaceuticals

from Wikipedia, the free encyclopedia
Vertex Pharmaceuticals Inc.

logo
legal form Corporation
ISIN US92532F1003
founding 1989
Seat Boston , United StatesUnited StatesUnited States 
management Jeffrey Leiden (CEO)
Number of employees 2,500 (2019)
sales 3,048,000,000 US dollars (2018)
Branch Pharma
Website www.vrtx.com.com

Vertex Pharmaceuticals is a US-based biopharmaceutical company with headquarters in Boston ( Massachusetts ). The company develops drugs to treat cystic fibrosis , cancer , intestinal diseases, autoimmune diseases and neurological diseases . Vertex is also active in the field of gene therapy .

history

Vertex was founded in 1989 by Joshua Boger and Kevin J. Kinsella . By 2004, the company had developed products for viral infections, inflammatory and autoimmune diseases, and cancer. In 2009 the company had around 1,800 employees, including 1,200 in the Boston metropolitan area. In 2019 the company employed around 2,500 people.

In January 2014, Vertex completed its move from Cambridge to Boston and moved into a new $ 800 million complex. For the company located on the coast of South Boston, the first time in the company's history was that all of its 1,200 or so Vertex employees worked together in the greater Boston area.

In September 2019, the company announced that it would acquire Semma Therapeutics for $ 950 million.

Others

The company's founding and early influence was described in the 1994 book The Billion-Dollar Molecule by journalist Barry Werth .

Web links

Individual evidence

  1. ^ Robert Weisman: Rearranging the Corporate DNA . In: Boston.com . April 24, 2011 ( boston.com [accessed December 1, 2019]).
  2. ^ Vertex Pharmaceuticals Reports Fourth Quarter and Full Year 2004 Financial Results and Full Year 2005 Guidance. Accessed December 1, 2019 .
  3. ↑ New complex unites Vertex employees - The Boston Globe. Retrieved December 1, 2019 (American English).
  4. ↑ Vertex to buy cell therapy developer Semma for $ 950 million . In: Reuters . September 3, 2019 ( reuters.com [accessed December 1, 2019]).
  5. ^ Barry Werth: The Billion-Dollar Molecule: The Quest for the Perfect Drug . Simon and Schuster, 1995, ISBN 978-0-671-51057-2 ( google.de [accessed December 1, 2019]).